Avi Reichental
Analyst · Canaccord. Please state your question
Good morning, everyone, and thanks for joining us today. For the fourth quarter of 2014, we generated record revenue of $187.4 million, representing a 21% increase over the comparable 2013 quarter despite significant foreign currency headwinds that reduced our total revenue by some-some $6 million during the quarter. We reported GAAP earnings of $0.01 per share and non-GAAP earnings of $0.21 per share. Notwithstanding the challenging operating environment in Europe, we recorded an impressive 46% revenue increase from EMEA, driven by 28% organic growth. Channel productivity primarily in North America fell well short of our expectations restricting our total organic growth to 7% for the quarter. Direct metals revenue increased by 178% and healthcare revenue grew by 26% with both vertical decisively surpassing industry growth rates. Consumer revenue increased substantially over the same period growing by 68% as our new product gained momentum. All told, our product category was the most negatively impacted by foreign currency growing only 16% while services revenue increased 33% Our order book held steady at $46.5 million even as revenue increased by 12% sequentially, reflecting robust demand for our products and services. We generated $24 million of cash from operations during the fourth quarter and ended the year with $285 million of cash on hand. For the full-year, we are pleased with the overall performance of our key verticals, but not so much with regional weaknesses in our channel coverage. Within our verticals, our design and manufacturing category grew by 27% over 2013 and revenue from our rapidly expanding healthcare category increased by 80%. Consumer revenue increased 26% to $43.8 million, rebounding strongly later in the year as we commenced commercial shipments of our newest consumer printers. We are definitely disappointed that we were not able to fully capitalize faster on the strength of our portfolio and closed the revenue gap that was caused by delayed consumer product and direct metal capacity constraints. This product availability headwinds and weakening channel performance primarily, in North America, suppressed our annual organic growth rates to 13%. The strategic investments that we made to build in end-to-end 3D healthcare business continued to deliver impressive results. Specifically, for the quarter, healthcare products and services revenue grew to $42.8 million, a 96% increase over the same period last year on strong organic growth. Throughout 2014, we acquired three strategic healthcare businesses, Medical Modeling, LayerWise and Simbionix. With these assets in hand, we can deliver the full benefits of personalized medicine through custom-made surgical instruments implants and devices. Under the very capable leadership of Kevin McAlea, whom we recently named Chief Operating Officer, Healthcare, we are moving quickly to fully integrated these assets extend our 3D healthcare solutions from the training room to the operating room. We believe that our proprietary 3D healthcare product and services address a truly open ended opportunity and position us to deliver a long-term beneficial outcome for providers and patients alike. Our decisive investments in both, acquiring and further developing proprietary direct metal printing products contributed to revenue growth of 178% for the quarter and 175% for the full-year compared to our 2013 pro forma results. With a benefit of the second manufacturing facility in operation during the fourth quarter, we increased our metal revenues from 73%, sequentially, and ended 2014 in the higher end of our direct metal revenue guidance range of $25 million $50 million. We see open ended opportunities for our direct metal products and services, primarily in aerospace, automotive and medical applications and we believe that we can leverage decades of domain expertise in these verticals to help our customers, manufacturer, flight-ready aerospace parts, functional automotive assemblies and production tire molds and ready to use medical devices. Additionally, during the fourth quarter, we took steps to equip several Quickparts and healthcare facilities with 10 direct metal printers that are expected to be in full operation by mid-year. We shipped 70% more design and manufacturing printer units in 2014 than the previous year and strong demand for our extended portfolio of SLA printers resulted in a 356% increase of total unit shipped. We also shipped 89% more SLS printers and increased placement of direct metal printers by 167% compared to 2013 pro forma. Our jetting category delivered only modest printer units growth as a result of North American channel weakness. Our EMEA channel performance delivered revenue growth of 46% for the quarter and 47% for the year, including organic growth of 28% and 33%, respectively. This is particularly impressive given the foreign currency headwinds that we faced with substantially compressed revenue in the fourth quarter. By contrast, channel productivity primarily in North America, fell well short of our revenue expectations restricting our overall organic growth to just 7% for the quarter. Under the leadership of our COO, Mark Wright for taking decisive steps to improve the productivity and coverage of our North American and APAC channel, to the level of our EMEA region. Specifically, we have reorganized and strengthened our North American senior leadership, we aligned our North American and APAC channel growth plans and incentives to closely mimic our successful EMEA program and we are investing in specific channel extension initiatives as well as productivity and training tools. I fully expect us to deliver meaningful results from these corrective actions as the year progresses. Our effective R&D investments contributed to a 44% increase in new products revenue over the past two years and delivered 27 new products last year alone. Included in our 2014 R&D investments was the strategic addition of the Xerox Wilsonville team that is working on several breakthrough new products that are designed to fuel incremental revenue growth beginning in the second half of 2015. With that, I would like to turn the call over to Ted Hull, our CFO, who will discuss our financial results in more detail. Ted?